These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years. Fusi-Rubiano W; Mukherjee C; Lane M; Tsaloumas MD; Glover N; Kidess A; Denniston AK; Palmer HE; Manna A; Morjaria R BMC Ophthalmol; 2018 Feb; 18(1):62. PubMed ID: 29486754 [TBL] [Abstract][Full Text] [Related]
23. Correlation of Central Macular Thickness and the Best-Corrected Visual Acuity in Three Months After Cataract Surgery by Phacoemulsification and With Intraocular Lens Implantation. Bamahfouz A Cureus; 2021 Mar; 13(3):e13856. PubMed ID: 33859906 [TBL] [Abstract][Full Text] [Related]
24. Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results. Kandasamy R; Constantinou M; Rogers SL; Sandhu SS; Wickremasinghe S; Al-Qureshi S; Lim LL Br J Ophthalmol; 2019 Dec; 103(12):1753-1758. PubMed ID: 30819688 [TBL] [Abstract][Full Text] [Related]
26. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Ciardella AP; Klancnik J; Schiff W; Barile G; Langton K; Chang S Br J Ophthalmol; 2004 Sep; 88(9):1131-6. PubMed ID: 15317702 [TBL] [Abstract][Full Text] [Related]
27. Quantification of fluid resorption from diabetic macular oedema with foveal serous detachment after dexamethasone intravitreal implant (Ozurdex Hodzic-Hadzibegovic D; Ba-Ali S; Valerius M; Lund-Andersen H Acta Ophthalmol; 2017 May; 95(3):324-325. PubMed ID: 27778454 [TBL] [Abstract][Full Text] [Related]
28. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema. Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940 [TBL] [Abstract][Full Text] [Related]
29. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Virgili G; Menchini F; Murro V; Peluso E; Rosa F; Casazza G Cochrane Database Syst Rev; 2011 Jul; (7):CD008081. PubMed ID: 21735421 [TBL] [Abstract][Full Text] [Related]
30. Factors Influencing Response to Aflibercept in Diabetic Macular Oedema Patients in a Diverse North West London Population: A Real-World Study. Sim SY; Ghulakhszian A; Minocha A; Ramcharan D; Nokhostin S; Cheong-Leen R; George S; Posner E; Dinah C Clin Ophthalmol; 2021; 15():2089-2097. PubMed ID: 34045845 [TBL] [Abstract][Full Text] [Related]
31. Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! Registry. Bhandari S; Biechl AC; Nguyen V; Squirrell D; Mehta H; Barthelmes D; Gillies MC Clin Exp Ophthalmol; 2020 May; 48(4):462-469. PubMed ID: 31885185 [TBL] [Abstract][Full Text] [Related]
32. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of choroidal thickness, macular thickness, and aqueous flare after cataract surgery in patients with and without diabetes: a prospective randomized study. Ikegami Y; Takahashi M; Amino K BMC Ophthalmol; 2020 Mar; 20(1):102. PubMed ID: 32169068 [TBL] [Abstract][Full Text] [Related]
34. [Dexamethasone intravitreal implant (Ozurdex) in patients with diabetic macular edema: Real life safety and efficacy]. Majstruk L; Qu-Knafo L; Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A J Fr Ophtalmol; 2020 Mar; 43(3):197-204. PubMed ID: 32000989 [TBL] [Abstract][Full Text] [Related]